Regression of 180J sarcoma after treatment with substituted indoloquinolinones.
D000818:Animals; D004353:Drug Evaluation, Preclinical; D005260:Female; D007211:Indoles / Q000627:therapeutic use; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D009368:Neoplasm Transplantation; D011804:Quinolines / Q000627:therapeutic use*; D012510:Sarcoma 180 / Q000188:drug therapy*
D007211:Indoles; D011804:Quinolines